During a 4.5-year period, 5 patients underwent reresection of colorectal liver metastases. Two patients died of recurrent disease, 9-11 months after reresection. Three patients are alive, one without and two with recurrent disease, 15, 15 and 68 months after reresection. Although our results suggest that liver reresection may be meaningful in selected patients with colorectal liver metastases, further studies are necessary in order to define candidates for this procedure.
INTRODUCTION
Liver resection gives 5-year survival rates of about 30% in both primary colorectal and primary liver cancer1'2. Except for dearterialization procedures for carcinoid liver disease, and liver transplantation for primary liver cancer3'4, no other treatment has been demonstrated to achieve cure or long-term palliation in malignant liver disease.
Treatment of recurrent cancer after liver resection is usually palliative and may include chemotherapy. Relapse 
RERESECTION OF THE LIVER
Recurrent disease in the liver was asymptomatic and detected at routine follow-up that included physical examination, liver function tests and computed tomography.
The interval between the first and second liver resections varied between 4 and 37 months with a median interval of 6 months ( Table 2) .
Wedge resections or larger, "atypical", resections were performed in all patients. The number of liver secondaries varied from 1-10; three patients had single wedge or atypical resections and two patients had an atypical resection combined with a wedge resection or resection of the caudate lobe.
RESULTS
The results are summarized in second hepatic resection was followed by meaningful palliation in some patients and, probably, survival benefit in a few6 '7. As for liver metastases, Nordlinger et al. reported the fate of 6 patients having undergone reresection for colorectal liver cancer: 2 patients were alive without evidence of disease after 2 and 12 months, 3 patients were alive with recurrent disease after 14, 16 and 28 months, and 1 patient died 10 months following reresection8. A similar experience was reported also by Fortner9.
In our study, it appears that the two patients with more than one deposit at reresection did not benefit from the procedure. On the other hand, it appears likely that reresection was beneficial in the two patients having single deposits at both the first and second liver resection and thus a cumulative number of 2 liver tumours.
For colorectal cancer, previous studies have indicated that (a first) liver resection is indicated when (a) the number of liver tumors is 3 or less, (b), extrahepatic tumor is not demonstrable, and (c) a resection margin of at least 10 mm can be 10 11 obtained Although the review of the literature and our own results indicate that few patients benefit from reresection of colorectal liver secondaries, our data suggest that reresection is worth a try in patients having a cumulative number of 2 liver metastases. However, further experience is needed for proper definition of reresection criteria.
The fact that four of the five patients have developed recurrent disease (hepatic recurrence in 2) emphasizes the inadequacy of presently available diagnostic methods (Table 2 ). Since 4 patients developed hepatic relapse within 7 months after the first liver resection, it should be noted that these recurrences did not occur at the site of the initial resection but were missed at the first operation. Anyhow, these early recurrences suggest that intraoperative ultrasonography should have been helpful in detecting these "occult" metastases at the first hepatic resection. The use of iatraoperative ultrasonography, now available at our and other centres, would lead to a better selection of patients for liver resection and, possibly, improved criteria for liver (re)resection.
Since the two patients with hepatic recurrence also had extrahepatic relapse, none of them would have been helped with liver transplantation. At any rate, the dismal experience with liver transplantation for "isolated" colorectal liver cancer 4'12'13 contraindicates liver grafting in patients with colorectal liver metastases.
